- Home
- VBFC vs CRVO Comparison
VBFC vs CRVO Comparison
Compare VBFC & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VBFC
- CRVO
- Stock Information
- Founded
- VBFC 1999
- CRVO 2001
- Country
- VBFC United States
- CRVO United States
- Employees
- VBFC N/A
- CRVO N/A
- Industry
- VBFC Major Banks
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- VBFC Finance
- CRVO Health Care
- Exchange
- VBFC Nasdaq
- CRVO Nasdaq
- Market Cap
- VBFC 117.6M
- CRVO 98.3M
- IPO Year
- VBFC N/A
- CRVO N/A
- Fundamental
- Price
- VBFC $77.50
- CRVO $2.11
- Analyst Decision
- VBFC
- CRVO Buy
- Analyst Count
- VBFC 0
- CRVO 8
- Target Price
- VBFC N/A
- CRVO $38.75
- AVG Volume (30 Days)
- VBFC 2.0K
- CRVO 303.4K
- Earning Date
- VBFC 01-27-2025
- CRVO 11-12-2024
- Dividend Yield
- VBFC 0.93%
- CRVO N/A
- EPS Growth
- VBFC 200.71
- CRVO N/A
- EPS
- VBFC 4.84
- CRVO N/A
- Revenue
- VBFC $32,098,999.00
- CRVO $10,066,550.00
- Revenue This Year
- VBFC N/A
- CRVO $34.17
- Revenue Next Year
- VBFC N/A
- CRVO N/A
- P/E Ratio
- VBFC $16.02
- CRVO N/A
- Revenue Growth
- VBFC 24.96
- CRVO 116.29
- 52 Week Low
- VBFC $40.11
- CRVO $1.80
- 52 Week High
- VBFC $80.91
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- VBFC 43.73
- CRVO 28.68
- Support Level
- VBFC $76.04
- CRVO $2.03
- Resistance Level
- VBFC $78.40
- CRVO $2.17
- Average True Range (ATR)
- VBFC 0.24
- CRVO 0.16
- MACD
- VBFC -0.15
- CRVO 0.30
- Stochastic Oscillator
- VBFC 50.17
- CRVO 23.08
About VBFC Village Bank and Trust Financial Corp.
Village Bank and Trust Financial Corp is a bank holding company. The banking is the primary operating business of the company. It offers a range of banking and related financial services, including checking, savings, certificates of deposit and other depository services, and commercial, real estate, and consumer loans, primarily in the Richmond, Virginia and Williamsburg, Virginia metropolitan areas. Its operating segment includes Commercial Banking and Mortgage Banking. The company generates maximum revenue from the Commercial Banking segment, which provides the mortgage banking segment with the short-term funds needed to originate mortgage loans through a warehouse line of credit and charges the mortgage banking segment interest based on the commercial banking segment's cost of funds.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.